News
Nurx, a leading telehealth platform specializing in women's health, is excited to announce an integration agreement with ...
Hims & Hers Health Inc.’s shares rose Tuesday after it said it was broadening its weight-loss offerings, adding access to brand name shots like Zepbound after previously focusing on cheaper versions ...
The telehealth company Hims & Hers is adding Zepbound and generic liraglutide to its offering of weight-loss drugs.
This integration with Gifthealth will streamline access to Zepbound®, an FDA-approved ... Nurx is committed to providing comprehensive telehealth care for women navigating weight management.
Eli Lilly's foray into telehealth shows the emerging importance virtual care platforms are playing in the rising popularity ...
Hims & Hers Health shares jumped Tuesday as the company added Eli Lilly’s weight-loss drug Zepbound and diabetes treatment Mounjaro to its telehealth platform.
Telehealth company Ro will offer single-dose vials of Eli Lilly's obesity therapy Zepbound in an expansion of the ways patients with a prescription can access the drug. The agreement means Ro has ...
U.S. regulators are trying to shut down the industry for compounded weight-loss drugs, which could result in higher costs or ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results